Literature DB >> 1858356

[The therapeutic efficacy of ribamidil and virazole in experimental Lassa fever in monkeys].

V I Dvoretskaia, G V Bogatikov, V A Pshenichnov, A A Evseev.   

Abstract

The therapeutic efficacy of ribamydil and virasol was evaluated in experimental Lassa fever in monkeys which received these drugs at various intervals after the onset of the clinical illness. Ribamydil or virasol administered in the first day of fever protected from death 60% to 66% of the infected animals, but when the drugs were given 2 days after the onset of fever the number of survivors declined to 0.20%. When the treatment was started 4 days after the onset of fever none of the drugs prevented deaths of Lassa virus-infected baboons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1858356

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  3 in total

Review 1.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

Review 2.  Molecular strategies to inhibit the replication of RNA viruses.

Authors:  Pieter Leyssen; Erik De Clercq; Johan Neyts
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970

3.  Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro.

Authors:  Stephan Günther; Marcel Asper; Christina Röser; Luciano K S Luna; Christian Drosten; Beate Becker-Ziaja; Peter Borowski; Huan-Ming Chen; Ramachandra S Hosmane
Journal:  Antiviral Res       Date:  2004-09       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.